USANA Health Sciences (NYSE: USNA) reported Q1 EPS of $0.95, $0.07 better than the analyst estimate of $0.88. Revenue for the quarter came in at $248 million versus the consensus estimate of $245.6 million.

For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.